Hytrin Articles
BI's Flomax shows good AE profile
18 July 2005
US states sue Abbott, Geneva and IVAX
2 October 2001
Generics industry poised for gold rush as blockbusters lose protection
13 September 2001
"Greed vs need" in US brand/generic deals
26 July 2000
Aventis and Andrx charged by US FTC
22 March 2000
Pfizer's Cardura "no better" than diuretic
16 March 2000
BI and Abbott to copromote Flomax in USA
19 August 1999
Mylan's Generic Aciclovir In USA
8 October 1998
US Generics Sector "Lacks Political Clout"
16 June 1998
US Generics Sector "Lacks Political Clout"
12 June 1998
Abbott Loses Apotex Battle
30 April 1998
Abbott Labs Victorious In Patent Lawsuits
9 April 1998
1997 Sales Reach $11.88 Billion At Abbott Labs
20 January 1998
Zocor "Will Be World's Top-Selling Drug In 2005"
13 January 1997
Terazosin Superior To Finasteride For BPH
2 September 1996
Global Branding Is A Must For Pharmaceuticals
12 August 1996
US FDA Seeks Comments On Consumer Ad Labeling
27 May 1996
VA Study Rates Hytrin Over Proscar
13 May 1996
US Block On Generics "Costing $5 Million A day"
11 March 1996
World Markets: Cancer, Cardiovascular, Menopause
19 February 1996
Proscar Versus Hytrin And Cardura For BPH
11 September 1995
Pryor Bill Backs Generics On GATT Patent Term
4 September 1995
Congress Faces Generic Drug Pressure Over GATT
24 July 1995
The ABPI's A-Z Of British Medicines Research
29 May 1995
Pfizer's Cardura Approved For BPH
13 February 1995
Abbott Posts Good Performance In 1994
23 January 1995
1993 A RECORD YEAR FOR ABBOTT
24 January 1994
ABBOTT'S HYTRIN GETS BPH APPROVAL IN USA
11 October 1993
ABBOTT ACHIEVES RECORD SALES
19 April 1993
FDA PANEL BACKS ABBOTT'S HYTRIN
15 March 1993
NEW CHEMICAL ENTITIES LAUNCHED IN 1992
1 February 1993
COMPARATIVE STUDY OF BPH TREATMENTS
18 January 1993
MERCK'S PROSCAR NEARING US APPROVAL
10 February 1992
Showing 1-40 of 40 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
